Yaron Ilan

June 9, 2025

A constrained disorder principle-based second-generation artificial intelligence digital medical cannabis system: A real-world data analysis

Abstract Introduction: Adhering to treatment plans can be challenging for medical cannabis patients. According to the constrained-disorder principle (CDP), biological…

June 5, 2024

A Feasibility Open-Labeled Clinical Trial Using a Second-Generation Artificial-Intelligence-Based Therapeutic Regimen in Patients with Gaucher Disease Treated with Enzyme Replacement Therapy

Abstract Background/Objectives: Gaucher Disease type 1 (GD1) is a recessively inherited lysosomal storage disorder caused by a deficiency in the…

January 24, 2022

Digital Medical Cannabis as Market Differentiator: Second-Generation Artificial Intelligence Systems to Improve Response

Abstract Legalized use of cannabis products and the rising interest in their therapeutic benefits have opened up new opportunities for…